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ABSTRACT 
Background: In recent years, deaths due to adverse drug reaction (ADR) have been on the increase. In order to 
reduce the untoward effects and to prevent deaths, reporting of ADR remains the cornerstone in improving 
patients safe use of drugs. Aim: This study aimed at assessing knowledge, attitude and practice of adverse drug 
reaction reporting amongst Medical Doctors, Pharmacists, and Nurses in selected health facilities within Abuja, 
Nigeria.Methods: A cross-sectional descriptive study was undertaken using questionnaire to assess knowledge 
attitude, and practice of reporting adverse drug reaction among the categories of healthcare workers included in 
the study.Results: The findings from the study showed that 99% of the study participants had knowledge about 
the standard definition of pharmacovigilance, majority of the study participants (58.7%) indicated that ADR 
reporting should be made mandatory, more than two third of the study participants (67%) had encountered cases 
of ADR in their practice, only a quarter of the participants (26%) had reported cases of adverse drug reaction. 
Conclusion: This study revealed that almost of the study participants were aware of ADR, they had sound 
knowledge and positive attitude towards ADR reporting but unfortunately the practice of reporting was low 
among healthcare professionals included for this study. 
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BACKGROUND 
A drug is defined as a substance or combination of substances presented as having properties for treating or 
preventing diseases in humans and animals (Goldman, et al., 2015). Drugs can sometime also produce 
undesirable effects besides desired pharmacological effects. These effects not related pharmacological actions of 
the drug are referred to as Adverse Drug Reactions (ADR) (Duarte, et al., 2015). Depending on the severity, 
ADRs can cause hospitalization or death. The International Conference on Harmonization (ICH) guidelines on 
Good Clinical Practice (GCP) defined ADR as a response to a drug that is noxious and unintended and occurs at 
doses normally used in human for prophylaxis, diagnosis or treatment of diseases, or for modification of 
physiological function (Abdel-Lateef and Abdel-Wahab, 2015). Adverse drug reaction is a global problem of 
major concern. It affects both children and adult with varying degrees, causing both morbidity and mortality.  
Adverse drug reaction reporting also known as “pharmacovigilance”, is the science dedicated to the study of 
safety of drugs, thus generating knowledge on the harmful effects of drugs both at the individual and population 
level so as to achieve safer use of drugs (Ohaju and Iribhogbe, 2010). 
In recent years, deaths due to ADRs have increased (Tahani, et al., 1998). A study conducted by Abubakar, 
et al. (2014) observed that 5% to 10% of patients were admitted to hospitals as a consequence of ADR. In 
several studies, the frequency was estimated to be 20% of all cases admitted to the geriatric department as well 
as in the internal medicine department. A study conducted by Lazrou, et al., (1998) concluded that incidences of 
serious ADRs reported were 6.7% and fatal ADRs were 0.32% of hospitalized patients. Proper monitoring of 
ADR is therefore a necessity for healthcare professionals.  
In Nigeria, healthcare professionals including medical doctors, nurses and pharmacists can report an ADR 
by filling the pharmacovigilance yellow form. Although several studies have evaluated the knowledge, attitude 
and practice of reporting adverse drug reaction among the healthcare professionals in Nigeria (Oshikoya and 
Awobusuyi, 2009; Fadare et al., 2011; Ogundele et al., 2012; Adedeji et al., 2013), no study has however been 
conducted in the Federal Capital Territory to include different healthcare professionals across different hospitals. 
It is a known fact that information regarding adverse drug reaction changes on a daily basis, hence the need for 
constant updating of the knowledge of healthcare workers in this area. It is against this backdrop that this study 
aimed at assessing, knowledge, attitude, and practice of ADR reporting amongst Medical Doctors, Pharmacists, 
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This study was conducted in three hospitals in Abuja Municipal area council (AMAC), in the Federal Capital 
Territory Abuja. These hospitals are National Hospital Abuja, Wuse General Hospital and Asokoro District 
Hospital. 
National Hospital Abuja is one of the major tertiary healthcare facilities that provides medical services to 
about ten million people (Alkali and Akano, 2013). The hospital also runs a postgraduate training to resident 
doctors and internship training to pharmacy interns and other profession in the health sector. The major 
departments in National Hospital Abuja include Pediatrics, Gynecology and Obstetrics, Surgery, Oncology, 
Internal Medicine and the National Trauma Centre. 
Asokoro general hospital and Wuse general hospital are both located in the heart of the Federal Capital 
Territory. They provide effective and affordable healthcare services. Their services cover both urban population 
and the rural areas surrounding the hospitals. They also serve as a referral centre and provide wide range of 
technical and administrative support and training. 
Study Design 
A well structured, self-administered questionnaire was developed. The questionnaire was adapted from a similar 
study that investigated the knowledge, attitude and practice of ADR reporting among physicians in Nigeria 
(Fadare, 2011). 
The questionnaire was designed to capture the following information; demographics data as well as 
knowledge, attitude and practice of the respondents towards ADR. The questionnaire was finalized after a series 
of revisions by taking into consideration the valuable comments from colleagues and advisors.  
Sample Population 
The population consists of National Hospital Abuja having 308 medical doctors, 652 nurses, and 53 pharmacists, 
Wuse General Hospital having 109 medical doctors, 208 nurses, and 26 pharmacists, and Asokokoro District 
Hospital having 100 medical doctors, 260 nurses and 45 pharmacists. These information from the three hospitals 
were all gotten from the office of the directorate of administration.  
Inclusion and Exclusion Criteria 
Doctors, nurses and pharmacists across all cadres in the three hospitals were included. Other healthcare 
professionals like medical laboratory scientists, radiographers and physiotherapists were excluded from the study. 
Sample Size 
There were total number of 1851 Doctors, Pharmacists, and Nurses in the three health facilities used for this 
study. The sample size was therefore calculated using Yamane, (1973) Formula which is stated below. 
n =   
Where: 
n = corrected sample size, 
N = population size (1851),  
e = Margin of error (MoE), e = 0.05.  
 
n =   
n = 393.62 
The calculated sample size was rounded up to 500 so as to account for non-responses. 
Data Analysis 
Information from the returned questionnaires were coded and entered into Statistical Package for the Social 
Sciences (SPSS) version 20, univariate analysis was undertaken to yield descriptive statistics.  
Ethical Consideration 
Ethical Approval was obtained from the Health Research Ethics Committee of the Federal Capital Territory and 




Out of the 500 questionnaires that were administered, a total number of 387 were completed and returned, 
thereby giving a response rate of 77.4%. Majority of the study participants were nurses (58.7%), two third of the 
participants were females (66.2%), three quarter of the study participants were married (74.0%), and a third of 
the study participants had between 6 and 10 years working experience. Further details on socio-demographic 
characteristics are presented in table 1 below. 
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Table 1: Demography 
Variables Frequency (%) 
Gender  
Male 132 (33.8) 
Female 259 (66.2) 
Age  
18 – 35  166 (51.7) 
36 – 45  113 (35.2) 
46 – 65  42 (13.1) 
Profession  
Doctor 123 (31.8) 
Nurse 227 (58.7) 
Pharmacist 37 (9.6) 
Marital status  
Single 94 (24.2) 
Married 287 (74.0) 
Divorced 2 (0.5) 
Widowed  5 (1.3) 
Years of Experience  
1 – 5  89 (24.3) 
6 – 10  127 (34.6) 
11 – 15  71 (19.8) 
16 - 20 36 (9.8) 
Above 20 years 44 (12.0) 
Knowledge of Pharmacovigilance and Adverse Drug Reaction Reporting (ADR) 
Almost all the study participants (99.0%) knew the standard definition of “pharmacovigilance”. A strong 
majority of the study participants (92.1%) indicated that not all drugs in the market are safe, and considerable 
proportion of the study participants (84.8%) indicated that the act of reporting ADR is their professional 
obligation. Further details relating to knowledge of pharmacovigilance and ADR are presented in table 2 below. 
Table 2: Knowledge of Pharmacovigilance  
Variable Yes No Not sure 
The word “Pharmacovigilance” is defined as the science of 
detecting, assessing, understanding and preventing adverse drug 
reaction (ADR). 
385 (99.0) - 4 (1.0) 
The most important purpose of pharmacovigilance is to assess safety 
of drugs and identify previously unrecognized ADRs.  
381 (97.7) 2 (0.5) 7 (1.8) 
Do you think that ADR reporting is professional obligation for you? 330 (84.8) 15 (3.9) 44 (11.3) 
Are you aware of any drug that has been banned from use? 319 (84.4) 15 (3.9) 44 (11.3) 
Do you believe that all drugs available in the market are safe? 10 (2.6) 359 (92.1) 21 (5.4) 
Is there a pharmacovigilance centre in your facility?  162 (41.3) 50 (12.8) 180 (45.9) 
Do you know about the “Yellow form” for reporting adverse drug 
reaction? 
244 (62.6) 116 (29.7) 30 (7.7) 
If response to B7 above is “yes”, then, is the yellow form available in 
your facility? 
113 (35.5) 31 (9.7) 176 (55.0) 
Do you know that you can get the Pharmacovigilance yellow form 
from NAFDAC website online, fill and submit? 
124 (32.0) 170 (43.9) 93 (24.0) 
Are you aware that there is a National Pharmacovigilance Centre in 
NAFDAC? 
265 (68.8) 68 (17.7) 52 (13.5) 
Do you think the ADR reporting and monitoring system will benefit 
the patient? 
382 (97.7) -  9 (2.3) 
Attitude Towards Pharmacovigilance and ADR Reporting 
Almost all the study participants (99.8%) indicated that reporting ADR is necessary, three quarter of the sample 
(74.5%) indicated the need for confidentiality to be maintained while reporting ADR. Half of the study 
participants (49.1%) agreed that ADRs are not adequately reported presently, whilst 60% of the participants 
indicated that the National Agency for Food and Drug Administration and Control (NAFDAC) has not created 
enough awareness and training regarding pharmacovigilance and ADR reporting. Other relevant details relating 
to attitude towards pharmacovigilance are presented in table 3 below.  
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Table 3: Attitude Towards Pharmacovigilance  
Variable Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
Reporting ADR is necessary. 325 (83.8) 62 (16.0) 1 (0.3) -  -  
ADR reporting is voluntary but 
should be made mandatory. 
227 (58.7) 121 (31.3) 22 (5.7) 15 (3.9) 2 (0.5) 
Confidentiality should be maintained 
while reporting ADR 
136 (35.4) 150 (39.1) 59 (15.4) 38 (9.9) 1 (0.3) 
Legal problems are a concern while 
reporting ADR. 
63 (16.5) 189 (49.6) 84 (22.0) 43 (11.3) 2 (0.5) 
At present ADRs are adequately 
reported and documented. 
43 (11.1) 65 (16.8) 89 (23.0) 188 (48.6) 2 (0.5) 
NAFDAC has created sufficient 
awareness on ADR reporting. 
15 (3.9) 47 (12.2) 90 (23.4) 229 (59.5) 4 (1.0) 
Practice of Monitoring and Reporting ADR 
Findings from this study indicated that more than three quarter of the participants (78.5%) had never filled the 
yellow form, less than a quarter of the participants (20.7%) had filled the yellow form ≤ 20 times, whilst only 8% 
of them had filled the form > 20 times. Slightly above a third of the sample (78.5%) indicated that they normally 
fill the yellow form after an ADR encounter in ≤ 1 week, less than a quarter of the sample (20.5%) indicated that 
they normally report ADR event ≤ 3 months after encounter, and 9.6% indicated that they report ADR > 3 
months after encounter. Further details relating to practice of monitoring and reporting ADR are presented in 
table 4 below.  
Table 4: Practice of Monitoring and Reporting ADR 
Variable  Yes No Not Sure 
Have you ever experienced adverse drug reaction in your 
patient during your professional practice? 
265 (68.7) 12 (3.1) 109 (28.2) 
Have you ever reported an adverse drug reaction to the 
pharmacovigilance unit? 
103 (26.8) 277 (71.9) 5 (1.3) 
Only pharmacists, nurses and doctors are responsible for 
reporting adverse drug reaction. 
69 (17.9) 80 (20.8) 236 (61.3) 
After submitting your report, did you get any feedback from 
the centre where you submitted? 
26 (16.0) 91 (56.2) 45 (27.8) 
If yes to the above question, were you comfortable with the 
feedback received? 
16 (15.7) 53 (52.0) 33 (32.4) 
Have you ever shared information about ADRs your patient 
encountered with anyone? 
233 (63.3) 121 (32.9) 14 (3.8) 
Have you ever been trained on how to report adverse drug 
reaction? 
83 (21.3) 291 (74.8) 15 (3.9) 
Do you feel that proper training should be provided to 
healthcare professionals on ADR reporting? 
364 (93.8) 8 (2.1) 16 (4.1) 
 
DISCUSSION 
Findings from this study revealed that almost all the respondents knew the meaning of the word 
“pharmacovigilance” and they also understood the purpose and concept of pharmacovigilance, suggesting that 
pharmacovigilance was not new to them. Drugs can produce both desirable and undesirable effect and it was 
observed that a large proportion of the study participants were aware that not all drugs in the market are safe as 
some may result to serious adverse reaction to some persons. Depending on severity, adverse drug reaction can 
cause hospitalization and even death (van der Hooft et al., 2006).   
Interestingly, a strong majority of the study participants indicated ADR reporting as part of their 
professional obligation and job description. This is however in contrast with an Ethiopian study where 
participants in that study indicated that ADR reporting is solely the responsibility of pharmaceutical companies 
(Abu et al., 2015). Available evidence suggest that healthcare workers have critical role to play regarding ADR 
reporting (Hanafi et al., 2012).  
Information gathered during preclinical and clinical trial are not enough to conclude safety of a particular 
drug, hence the need for continuous assessment and evaluation of drugs in the market. However, report shows 
that it is almost impossible to detect ADR from drugs which adverse drug reaction associated with them only 
occurs after prolong usage (Goldman et al., 1995).  A third of the study participants were aware that yellow form 
exists for reporting ADR, this is in contrast with previous findings among Nigerian doctors where low awareness 
about procedure for reporting ADR was reported (Oshikoya and Awobusuyi, 2009; Fadare et al., 2011; 
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Ogundele et al., 2012; Adedeji et al., 2013). Of those that claimed awareness of what “yellow form” is about, 
majority of them indicated that the form is not readily available for them to use. The non-availability of the form 
can limit their intentions to report cases of ADR. Also, more than two third of the study participants were aware 
of the existence of National Pharmacovigilance Centre which is domiciled in NAFDAC. This is in line with a 
previous Nigerian study (Joseph et al., 2011), but dissimilar with a study conducted in Cyprus (Granas et al., 
2007) where majority of respondents reported ignorance of the National body that collates ADR cases in that 
country. 
Findings from this study further indicates that only a third of the study participants were aware that “yellow 
form” for the reporting of ADR can be filled and submitted online to NAFDAC, suggesting the need for more 
awareness to be created among healthcare personnel in this regard. Creating this awareness will provide 
opportunity for healthcare personnel practicing in healthcare facilities where yellow forms are not readily 
available to be able to report cases of ADR directly to NAFDAC without delay. Also, only slightly above a third 
of the participants were aware of the existence of pharmacovigilance centre in their facilities, suggesting that 
majority of the participants may likely not report a case of ADR if they come across one.  
Participants in this study demonstrated a positive attitude towards reporting of ADR as almost all the 
participants indicated that reporting of ADR is necessary and strongly supported the need for ADR reporting to 
be made mandatory. These findings also corroborate previous findings (Green et al., 2001).  Majority of the 
study participants indicated that cases of ADRs are not adequately reported, and they also indicated that 
NAFDAC has not created sufficient awareness regarding ADR reporting. These findings therefore suggest the 
need for NAFDAC to increase awareness among healthcare workers on the need for reporting ADR.  
A third of the participants in this study seems to have had experience with patients affected with ADR in the 
course of carrying out their professional obligation, however, only a quarter of them had reported ADR to 
pharmacovigilance unit. These findings suggest low interest in the reporting of ADR event by healthcare 
workers. Although those that had filled the yellow form more than 20 times were relatively few, however, 
majority of those that had filled the yellow form usually take ≤ 1 week to do so. These findings suggest high 
level of enthusiasm among those that are already carrying out pharmacovigilance activities in their facilities. 
However, majority of those that had submitted yellow form to pharmacovigilance unit indicated that they did not 
receive any feedback after submission. This is an area that NAFDAC can improve upon so as to further 
encourage those interested in reporting ADR events, as not receiving feedback can reduce the morale of those 
that had previously reported cases of ADRs. 
 
CONCLUSION 
This study gives pertinent information regarding knowledge, attitude and practice of reporting adverse drug 
reaction and some factors that pose as barriers to reporting. The study revealed that even though majority of 
health professionals have positive attitude towards ADR reporting, reporting among health professionals was 
low. This could be due to low level of training and creation of awareness among health professionals towards 
ADR reporting. 
Awareness creation program on ADR reporting system, need to be designed for healthcare professionals by 
relevant bodies like NAFDAC. ADR reporting system need to be introduced and given emphasis at the higher 
institution training. Also, establishing strong feedback and increasing options of reporting would improve the 
reporting system.  
It is recommended that yellow forms be made available in all healthcare facilities, and continuous training 
of healthcare workers on pharmacovigilance be given priority attention. Furthermore, a reward system for 
healthcare workers on ADR reporting can go a long in encouraging the reporting of ADR events. 
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